Word

LUZIPLA

Status

Dead

Status Code

709

Status Date

Friday, August 5, 2022

Serial Number

79163260

Registration Number

4887302

Registration Date

Tuesday, January 19, 2016

Mark Type

5000

Filing Date

Monday, December 22, 2014

Published for Opposition

Tuesday, June 2, 2015

Cancellation Date

Friday, August 5, 2022

Trademark Owner History

SHIONOGI & CO., LTD. - Original Registrant

Classifications

5 Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases, diabetes, obesity, cancer, endocrine disorders, hormonal diseases and disorders, urological disorders, sexual dysfunction, [ HIV and AIDS, ] central nervous systems diseases and disorders, peripheral nervous system diseases and disorders, osteoporosis, rheumatism, neurological disorders, pain, gastrointestinal disorders, respiratory diseases and disorders, allergies, bacterial disorders, [ viral disorders, ] fungal disorders, infectious diseases * other than HIV and AIDS *, inflammation and inflammatory diseases, sepsis, immunological disorders * other than HIV and AIDS *, musculoskeletal disorders, disease and disorders of the liver, allergic rhinitis, and opioid-induced constipation [ ; ] *, except pharmaceutical preparations for the treatment of viral disorders * pharmaceutical preparations for treating thrombocytopenia

In the Statement, line 8, 'HIV AND AIDS," should be deleted, and, In the Statement, line 12, "VIRAL DISORDERS," should be deleted. In the Statement, line 12, after INFECTIOUS DISEASES, "OTHER THAN HIV AND AIDS" should be inserted, and in the Statement, line 13, after IMMUNOLOGICAL DISORDERS, "OTHER THAN HIV AND AIDS" should be inserted.
In the Statement, line 8, 'HIV AND AIDS," should be deleted, and, In the Statement, line 12, "VIRAL DISORDERS," should be deleted. In the Statement, line 12, after INFECTIOUS DISEASES, "OTHER THAN HIV AND AIDS" should be inserted, and in the Statement, line 13, after IMMUNOLOGICAL DISORDERS, "OTHER THAN HIV AND AIDS" should be inserted. In the statement, line 15, after constipation; ", except pharmaceutical preparations for the treatment of viral disorders " should be inserted.
Color is not claimed as a feature of the mark.

Trademark Events

Jun 5, 2023

Total Invalidation Processed By The Ib

May 15, 2023

Total Invalidation Of Reg Ext Protection Sent To Ib

May 15, 2023

Invalidation Processed

Apr 5, 2023

Total Invalidation Of Reg Ext Protection Created

Aug 5, 2022

Cancelled Section 71

Dec 20, 2017

Invalidation Reviewed - No Action Required By Office

Dec 11, 2017

Partial Invalidation Of Reg Ext Protection Created

Jun 23, 2017

Partial Invalidation Processed By The Ib

Apr 11, 2017

Correction Under Section 7 ¿ Processed

Apr 11, 2017

Case Assigned To Post Registration Paralegal

Mar 31, 2017

Partial Invalidation Of Reg Ext Protection Sent To Ib

Mar 31, 2017

Invalidation Processed

Mar 23, 2017

Limitation From The Ib Examined And Entered

Mar 2, 2017

Limitation Of Goods Received From Ib

Oct 28, 2016

Partial Invalidation Of Reg Ext Protection Created

Sep 9, 2016

Notification Processed By Ib

Apr 19, 2016

Final Disposition Notice Sent To Ib

Apr 19, 2016

Final Disposition Processed

Mar 10, 2016

Limitation From The Ib Examined And Entered

Feb 28, 2016

Correction Under Section 7 ¿ Processed

Feb 19, 2016

Limitation Of Goods Received From Ib

Feb 18, 2016

Grant Of Protection Created, To Be Sent To Ib

Jan 19, 2016

Registered-Principal Register

Dec 14, 2015

Extension Of Time To Oppose Process - Terminated

Jul 2, 2015

Extension Of Time To Oppose Received

Jun 2, 2015

Published For Opposition

May 13, 2015

Notice Of Publication

Apr 21, 2015

Application Filing Receipt Mailed

Apr 20, 2015

Approved For Pub - Principal Register

Apr 15, 2015

Assigned To Examiner

Apr 15, 2015

New Application Office Supplied Data Entered

Apr 13, 2015

Limitation From Original Application Entered

Apr 9, 2015

Sn Assigned For Sect 66a Appl From Ib